          |
Illicit Drug Policies: Selected Laws from the 50 States (2000)
outlines selected statutory provisions addressing four major issues:
(1) controlled substances scheduling, (2) penalties for sale or possession
of selected substances, (3) penalties for sale or possession of crack
cocaine, and (4) medical marijuana provisions. All chart book data reflect
laws in effect as of January 1, 2000. The chart book data are available
in the following separate data files:
-
Controlled
Substances Scheduling (2000
Scheduling Data.xls - 24.9 KB; Codebook
(PDF) - 125 KB) - Shows into which categories federal and state
governments have placed each substance of interest according to guidelines
based on potential for abuse, likelihood for dependence, and the drug's
currently accepted medical use, if any. The particular substances
of interest are Marijuana, Cocaine, Methamphetamine, Rohypnol, GHB,
Ecstasy (MDMA), and Ketamine. Generally, schedules are in decreasing
order dependent upon danger or abuse, with Schedule I substances having
the highest potential for abuse and Schedule V (or lower schedule)
substances typically reflecting substances that have a very low potential
for abuse.
-
Penalties
for Sale or Possession of Selected Substances (2000
Chartbook Penalty Data.xls - 149 KB; Codebook
(PDF) - 124 KB) - Presents information on sale and possession
penalties associated with initial violations. Data presented for first
offense violations involving Marijuana, Cocaine, Methamphetamine,
and Ecstasy. Includes: (a) applicable quantity triggers (up to the
first three) differentiating among penalties, (b) maximum and minimum
fines applied to each quantity, (c) maximum and minimum imprisonment
applied to each quantity. Notations are made indicating whether or
not there is an increased penalty for subsequent violations.
-
Separate
Penalties for Selling or Possessing Crack Cocaine - (2000
Chartbook Sep Penalty Crack Data.xls - 21.5 KB; Codebook (PDF)
- Codebook
(PDF) - 123 KB)) A dichotomous indicator as to whether the state
imposes different penalties for the sale and/or possession of crack
cocaine (as compared to cocaine powder).
-
-
enable
establishment of Therapeutic Research Programs (TRP) to study
the medicinal value of marijuana for specific categories of patients
and/or diseases (participating patients and physicians are protected
from state and federal prosecution)
-
reclassify
marijuana to a lower schedule in recognition of the medicinal
value of its use outside of a TRP
-
enable
physicians to prescribe marijuana for medical use or discuss with
patients the medicinal value of marijuana outside of a TRP
-
provide
a medical necessity defense to patients and/or their caregivers
for using and/or possessing marijuana for medicinal purposes.
HOME
| ABOUT US | PROJECT TEAMS | RESEARCH PRODUCTS
| NEWS RELEASES
RELATED PROJECTS
| OTHER WEBSITES | MEMBERS | CONTACT US
|
